$BRSF Covid-19 Antibodies Found in Placentas of Infected Pregnant Women

$AZRX 5 Hot Penny Stocks Analysts Rate A Buy Right Now But Do You Agree?

Hot Penny Stocks To Buy According To These Analysts

Are you looking for penny stocks to buy right now ? You’re not alone, and, in fact, some of the hottest names in the stock market today are these cheap stocks under $5. With the Biden Administration’s stance on small-business, the thought track among analysts is that smaller companies could flourish. Whether or not this comes to fruition by the end of Biden’s term is to be seen. However, what we do notice is that small-cap ETFs are red hot right now.

Just look at the broader market ETFs like the SPY and QQQ and compared them to something like the Russell 2000 Small-Cap ETF ( NYSE: IWM ). While all have reached new all-time highs this week, one stands out for its overall performance for the year so far. The SPY is up around 4.5%, with the QQQ up slightly higher at 6.4% for the year. If you look at the IWM, though, you’ll see something a bit more exciting.

From the opening bell on January 4th to its all-time high on February 10th, the IWM ETF has climbed 16.3% this year. That’s more than the QQQ and SPY combined. What’s more, is that momentum hasn’t wavered either. We’ve seen this type of action relatively consistent over the last few months, even before the new year.

So it stands to reason that analysts are growing more bullish on small-cap stocks right now. Not all of these are considered penny stocks , though. But for this article, we’re going to only focus on a few hot stocks under $5. Will they be the best ones to buy in February? According to 4 analysts, they seem very bullish as of their latest ratings. Do you agree?

Hot Penny Stocks To Buy [According To Analysts]

• Drive Shack Inc. ( NYSE: DS )
• Allied Esports ( NASDAQ: AESE )
• Cinedigm Corp. ( NASDAQ: CIDM )
• Corbus Pharmaceuticals Holdings ( NASDAQ: CRBP )
• AzurRX BioPharma ( NASDAQ: AZRX )

Drive Shack Inc.

Drive Shack has long been on our list of penny stocks to watch. Whether it was in conversations about entertainment stocks or others about epicenter penny stocks, DS has continued gaining interest from investors. What’s more, analysts have also grown bullish on the stock. B. Riley’s last rating was a Buy, and it put a $5.50 price target on Drive Shack. Considering that shares are still trading below $2.80, that puts the DS stock forecast price nearly 100% higher as of this week.

If you’re unfamiliar with the company, Drive Shack operates a portfolio of golf-centric entertainment businesses. This includes the original Drive Shack (similar to a Top Golf for those familiar). It also has plans to roll out its new Puttery venues this year. Drive Shack partnered with famed golfer Rory McIlroy to market the new brand and plans on breaking ground in Dallas this summer for its first location.

Late last month, the company announced a $50 million offering. While shares dropped in the short term, things have quickly rebounded recently. The funds have been earmarked for corporate purposes, including the planned development of five of seven Puttery venues in 2021.

Allied Esports

One of the hot tickets of 2020 and 2021 have been virtual gaming. With the entire world seeming shut down last year, one of the leading sports to weather that storm was Esports. As far as Allied is concerned, the company just sold off its World Poker Tour asset to Element Partners for just over $78 million. That deal is expected to be closed up in the very near-term. Allied is also looking at strategic options for the Esports business. This includes a possible sale.

[Read More] Cheap Energy Penny Stocks To Buy For Under $5 In February 2021

While this may be the case right now, it doesn’t seem like Allied is shying away from the “main stage,” so to speak. The company just renewed its exclusive naming rights agreement for Allied Esports’ global flagship property, HyperX Esports Arena Las Vegas. Located at Luxor Hotel and Casino on the Las Vegas Strip, it’s been designed as a global destination for esports fans. Whatever the outcome of this “strategic” approach to its current business model is to be seen.

But what we can say is that right now, analysts appear bullish on the stock. As of its last rating, Stephens has Allied at “Overweight,” and the firm set a $4 target on the penny stock.

Cinedigm Corp.

Cinedigm Corp. is another one of the tech/entertainment stocks to watch this year. Actually, since early November, CIDM stock has been in an upward trend. Thanks to digital entertainment taking a front seat during the pandemic, companies like Cinedigm have outperformed. In fact, during the period from November 2nd right through this week, CIDM stock has climbed as much as 375%.

The key point of focus for the company has been expanding its streaming services offerings. This includes the launch of Whistle TV streaming on Roku and MyTime Movie Network, in addition to acquiring over 1,000 hours of film and TV programming. The company also managed to significantly reduce its debt burden while even prepaying certain outstanding obligations related to specific principle, interest, fees, and expenses under its second lien loan deal this week. Furthermore, the company announced that its content distribution partnership with Rockbot allows it to distribute Cinedigm’s channels to 20 million monthly viewers.

Benchmark analysts are currently bullish on the stock as well. The firm’s last updated rating was a Buy. It also set a price target of $3.50.

Corbus Pharmaceuticals Holdings

There are two penny stocks with bullish ratings from H.C. Wainwright. The first on this list is Corbus Pharmaceuticals Holdings. It was one of the marijuana penny stocks we discussed earlier this week. Similar to CIDM, CRBP stock has been in a strong uptrend since early November. This period has seen the stock rally from around 90 cents to highs of $3.60 this week. Volume has also played a noticeable role in that time as well. The stock saw its highest, second-highest, and third-highest trading volume days in over a year within the last week.

With the Jazz Pharmaceuticals buyout of GW Pharma, biotech marijuana stocks are in the spotlight. Corbus Pharmaceuticals develops treatments targeting the endocannabinoid system. Corbus is looking to shorten its fully-enrolled Phase 3 dermatomyositis trial to 28 weeks from 52 weeks. Data is now expected as early as the second quarter of this year. So this could be something to look at in the shorter term. Other than that, the company hasn’t reported many new developments.

H.C. Wainwright currently has a Buy on the stock with a $3 price target. Thanks to the momentum in pot stocks this week, CRBP shares have surpassed that level already.

AzurRX BioPharma

Shares of AzurRX have maintained the higher levels that the stock had reached this week. Tuesday, the penny stock gapped up big on news that AzurRX engaged PPD, Inc.  (NASDAQ: PPD) for its planned Phase 2 clinical trial evaluating a proprietary formulation of micronized niclosamide as a treatment for COVID-19-associated gastrointestinal infections.  PPD is a global contract research organization.

Read More

• Best Penny Stocks Under $1? 3 For Your Watch List Today
• 4 Robinhood Penny Stocks For Your February 2021 Watch List

Daniel Burch, M.D., Senior Vice President and Global Head of PPD® Biotech, stated, “PPD is pleased to support AzurRx’s efforts to bring relief to patients suffering from COVID-19-related GI infections. We recognize the breakthrough nature of AzurRx’s work with FW-1022 and look forward to applying our capabilities and expertise to the development of FW-1022, beginning with the planned Phase 2 clinical trial.”

H.C. Wainwright lifted its price target on AZRX stock this week from $2 to $3.50. It also reiterated its Buy rating on the stock.

$BFGCD Announces C$15M Fully Subscribed Private Placement

Augusta Gold (CSE: G) (OTCQB: BFGCD) (FSE: 11B) today announced a fully subscribed non-brokered private placement raising approximately C$15 million. Per the private placement, Augusta will offer 6.7 million units at a price of C$2.25 per unit with each unit comprised of one (1) common share of the company (a “common share”) and one half (1/2) of one (1) common share purchase warrant (a “warrant”). Each full warrant entitles the holder to acquire one common share for a period of three years at an exercise price of C$2.80. Augusta Gold intends to utilize the proceeds to advance exploration efforts at its highly prospective wholly owned Bullfrog Gold project located in Nevada, USA, and for general and working capital purposes. The private placement is fully subscribed by the company’s insiders, including Richard Warke and other strategic investors.

To view the full press release, visit https://ibn.fm/Vq1zj

About Augusta Gold

Augusta Gold is a rapidly growing exploration and development company focused on building a long-term business that delivers stakeholder value through developing the Bullfrog Gold Project and pursing accretive M&A opportunities. The Bullfrog Gold Project is located in the prolific Bullfrog district approximately 120 miles northwest of Las Vegas, Nevada and four miles west of Beatty, Nevada. The company controls approximately 7,800 acres of mineral rights including the Bullfrog and Montgomery-Shoshone deposits and has further identified significant additional mineralization around the existing pits and defined several exploration targets that could further enhance the project. The company is led by a management team and board of directors with a proven track record of success in financing and developing mining assets and delivering shareholder value. For more information, visit www.AugustaGold.com.

NOTE TO INVESTORS: The latest news and updates relating to BFGCD are available in the company’s newsroom at http://ibn.fm/BFGCD

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

$XPHYF 2021 Strategic Plan Showcases API Potential

$SRAX Sequire Provides Public Companies with Actionable Insights on Investor Activity While Severe Volatility Grips Markets

• Investor uncertainty rising as volatility continues to negatively affect stock market
• SRAX’s Sequire investor analytics platform provides actionable insights into investor behaviors for public companies
• Sequire has grown to 3 million+ active users across 90 public companies since 2019
• Q3 2020 performance includes $6.7 million in bookings, 37% increase in subscriptions, 161% year-over-year and 124% quarter-over-quarter revenue growth

Despite record levels of unemployment, threats of extreme inflation and runaway government spending, the stock market appears to have decoupled from the greater economy with record highs amid unprecedented levels of volatility (https://ibn.fm/fEiHi). As uncertainty among investors continues to grow, many public companies are choosing clarity over confusion through the use of Sequire, SRAX Inc.’s (NASDAQ: SRAX) SaaS platform that helps its users unlock the power of investor data so they can activate marketing campaigns that engage both current and prospective investors.

There’s never been a greater need for actionable, reliable investor data than in recent weeks. Market volatility has reached unparalleled levels, credited mostly to irrational trading, investor reactions to new government policies, derivatives speculation and anticipated earnings reports. “There’s a lot of news to digest for investors,” said J.J. Kinahan, chief market strategist at TD Ameritrade. “We’ve had such an incredible run, and 20% of the S&P 500 are releasing earnings this week.”

Sequire is the answer for many public companies looking to harness the power of big data for reliable analytics derived from the platform’s 3 million+ active users, a group which includes investors and traders from over 90 public companies (https://ibn.fm/0D6lL). The platform’s unique set of tools help users obtain insights through investor intelligence and outreach, warrant tracking, survey creation, event promotion and roadshows.

“The platform is an absolute game-changer for public companies and their shareholders,” said LD Micro founder Chris Lahiji in statements about the recent acquisition of the company by SRAX. “Both companies believe that one day executives will rely on Sequire the same way investors rely on Bloomberg.”

Sequire’s sales performance in 2020 was outstanding with over $6.7 million in bookings in Q3, its first positive quarter EBITDA. Along with a 37% increase in subscriptions, the platform experienced impressive 161% year-over-year and 124% quarter-over-quarter revenue growth.

“Sequire is changing the way public issuers interact with and engage their investors, and it shows,” said SRAX CEO and Founder Christopher Miglino (https://ibn.fm/I5gHA). “We are pleased to report our first quarter of positive EBITDA from our Sequire segment.”

Besides Sequire, SRAX is also focused on building the largest and most reliable opted-in data sets across a broad range of industry verticals. The Company is dedicated to providing brands and companies across the CPG, luxury, and lifestyle spaces with high-quality data that provides key, actionable insights integral to strategic marketing campaigns.

SRAX is a financial technology company that helps public companies unlock the power of data through Sequire, its premier investor intelligence and communications platform. Sequire helps companies track investor behaviors and identify trends for use in campaigns to engage current and potential investors across multiple marketing channels.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

$PBIO to Acquire Assets of International Agrochemical Developer and Supplier

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced its entry into a letter of intent to purchase the assets of an internationally based developer and supplier of organically natural, eco-friendly agrochemicals. The company offers sought-after alternatives to synthetic pesticides and fertilizers serving rapidly growing global sectors of organic and environmentally-sustainable agricultural production. “Upon completion, this acquisition of assets will bring into PBI an established portfolio of respected brand names in the eco-friendly agrochemicals market, with unique proprietary formulations, advantageous manufacturer relationships, trademarks, intellectual property, registrations and licenses, and access to distributor and end-customer relationships around the world,” said Richard T. Schumacher, president and CEO of PBI. “We expect these assets to be accretive, driving significant new revenues and profitability in 2021 and beyond.”

To view the full press release, visit http://ibn.fm/DLOBu

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$POAI Stands to Benefit from Explosive Growth of Precision Medicine

$PLTXF to Collaborate with LA Retail Hot Spot

PlantX (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF), a multifaceted marketplace providing consumers all things plant based, has announced a collaboration with Farm Cup Coffee. The collaboration should increase PlantX’s presence in one of LA’s most sought-after retail locations. The announcement noted that PlantX will display and sell its houseplants at Farm Cup Coffee’s new location in West Hollywood, California. The company’s plants include a wide range of types, from succulents to an exotic variety of potted flora. Farm Cup Coffee began as a mobile coffee shop, located in a Citroen van; the concept captured Farm Cup Coffee founders’ goal of living life sustainably; the company continues that commitment by focusing on organic coffee that has been ethically sourced from farm owners around the world. “Displaying our indoor plants in the highly attractive Farm Cup Coffee store in West Hollywood will expand PlantX’s reach to its customers and boost our brand visibility,” said PlantX founder Sean Dollinger in the press release. “We are thrilled to collaborate with the Farm Cup Coffee team, whose passion for sustainability is echoed by PlantX’s aim to inspire people to adopt healthier, more eco-friendly lifestyles.”

To view the full press release, visit https://ibn.fm/GxISK

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, PlantX currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. PlantX eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at http://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$RACMF Announces Contract to Provide COVID-19 Safety Protocols to Leading Canadian Ski Resort

Loop Insights (TSX.V: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick-and-mortar space, has been selected by Big White Sky Resort to execute its venue management-platform. The resort expects Loop Insights to facilitate complementary COVID-19 safety protocols for its visitors and staff using Loop’s proprietary platform. The announcement noted that the agreement has potential to generate $7.2 to $9.6 million in newline revenues for both companies. Loop Insights will instigate the safety protocols at all Big White Ski Resort and its facilities. The four-year, venue-management agreement notes that both parties anticipate generating revenue through monthly Software as a Service (“SaaS”) sources, fees generated per active Wallet pass and joint marketing opportunities offered through the Wallet pass. Big White Sky Resort is British Columbia’s second-most popular ski resort, with thousands of guests visiting every year. Loop plans on using its venue tracing technology to provide safety protocols for those guests as well as Big White Sky Resort employees. “We are proud to see the success TELUS has had offering Loop’s products through its IoT Marketplace to such key clients such as Big White Ski Resort,” said Loop Insights CEO Rob Anson in the press release. “The magnitude of this win cannot be overstated. Big White Ski Resort is not only a top Canadian ski resort but also a globally-renowned ski resort that will garner significant attention to our solution. Moreover, as a British Columbia company, Loop is proud to help one of the Province’s biggest tourist attractions via the implementation of our solution stack.”

To view the full press release, visit https://ibn.fm/Es75O

About Loop Insights Inc.

Loop Insights is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing and contactless solutions to the brick-and-mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. RACMF’s ability to integrate seamlessly into existing infrastructure and customize campaigns according to each vertical creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality and retail industries in Canada, the United States, the UK, Latin America, Australia, Japan and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network and sold through the TELUS IoT Marketplace. For more information about the company, please visit www.LoopInsights.ai.

NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at http://ibn.fm/RACMF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$ICLK Announces Collaboration with KLWTT to Offer Powerful Oracle CX Suite

iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, is working with KLWTT (“KLWTT”) in a collaboration with Oracle to offer the Oracle Advertising and Customer Experience (“CX”) suite to their customers. A leading provider of automated marketing services in Southeast Asia, KLWTT is also a member of Oracle PartnerNetwork (“OPN”). iClick and KLWTT’s customers can utilize the CX suite to take full advantage of the combined expertise of all companies involved: iClick’s strengths in programmatic marketing and data; KLWTT’s leadership in implementing and executing automated marketing platform; and Oracle’s industry-leading CX cloud solutions. As the global pandemic has escalated the movement of business into the digital world, the ability to bring automated advertising and automated messaging together for the first time — true Marketing-as-a-Service — becomes crucial. “We’re delighted to announce our partnership with KLWTT to develop enhanced offerings that will help our clients across the region, including those in Greater China , adapt to the rapidly digitalising market environment,” said iClick co-founder and CEO Jian “T.J.” Tang. “Our clients will benefit from integrated access to both advertising and marketing automation solutions. We also view this as a great opportunity for iClick to rapidly gain market share for its Enterprise Solutions initiatives, as it allows us to leverage our data capabilities in a significant way.”

To view the full press release, visit https://ibn.fm/xZ6YU

About iClick Interactive Asia Group Limited

iClick Interactive is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, the company’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in 10 locations worldwide including Asia and Europe. For more information about the company, please visit www.iClick.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$GNPX Announces Formation of Clinical Advisory Board

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the formation of a Clinical Advisory Board (CAB) to support its oncology and diabetes development programs. Comprised of preeminent clinical specialists, the CAB will lead and advise Genprex as it advances its REQORSA™ immunogene therapy program, including its Acclaim clinical trials in non-small cell lung cancer, and its preclinical diabetes gene therapy program. Some of the members also serve in additional roles at the Company.

“We are pleased to bring together this group of seasoned practitioners in the field of oncology and diabetes to guide and advise Genprex in advancing our clinical development programs,” said Genprex’s Chief Executive Officer, Rodney Varner. “The Clinical Advisory Board’s experience in clinical trials of cancer and diabetes therapies, combined with their expertise in consulting with small and large biotechnology companies, is invaluable as our drug candidates progress into the clinic.”

The members of Genprex’ Clinical Advisory Board include:

• Michael Morse, MD, MHS, FACP – Dr. Morse is a Professor of Medicine in the Division of Medical Oncology and Professor in the Department of Surgery at Duke University Medical Center, Durham, NC. His clinical expertise includes management of gastrointestinal malignancies including colon, hepatobiliary, gastroesophageal and pancreatic cancer. His research expertise includes the development of targeted therapies including immunotherapies for cancer. He has published extensively on topics in cancer immunotherapy, targeted therapies and gastrointestinal malignancies, including textbooks on Cancer Vaccines and Liver Tumors. Dr. Morse is Editor for Current Opinions in Biologic Therapies. He has been the principal investigator of a number of investigator-initiated and industry-supported phase 1 and 2 clinical trials of cancer immunotherapy and therapies for gastrointestinal malignancies. He is a member of the American Association of Cancer Research, the American Society of Clinical Oncology, the American Society for Clinical Investigation, American College of Physicians, and the Society for the Immunotherapy of Cancer.
• Col. George E. Peoples, MD, FACS – Dr. Peoples served 30 years of active duty as a surgeon and research scientist in the military. He is the Founder and Director of the Cancer Vaccine Development Program (CVDP), which has been focused on the discovery, development, and clinical testing of cancer vaccines for more than 20 years. Four of the program’s cancer vaccines have been licensed for commercial development. Dr. Peoples currently serves as the CEO of Cancer Insight, LLC, CVDP’s commercial counterpart, which is a boutique cancer immunotherapy Contract Research Organization conducting multiple Phase 1 and 2 clinical trials. He also serves as Professor of Surgery at the Uniformed Services University of the Health Sciences and Professor (adjunct) of Surgical Oncology at MD Anderson Cancer Center (MDACC). Dr. Peoples is the past Chair of the Cancer Care Program, San Antonio Military Medical Center and the past Military Director of the United States Military Cancer Institute. He is a graduate of the United States Military Academy, West Point and the Johns Hopkins School of Medicine. Dr. Peoples completed his surgical training at Harvard’s Brigham and Women’s Hospital and a surgical oncology fellowship at MDACC.
• Andrew B. Becker, MD, PhD – Dr. Becker is President and Founder of Becker Pharmaceutical Consulting, a market research, competitive intelligence and strategic planning consulting firm that provides analytic and strategy services to companies ranging from small biotechnology and medical device companies up to large multinational pharmaceutical companies on a global basis. Dr. Becker received both his medical degree and PhD in Molecular Pharmacology from Stanford University. At Stanford, Dr. Becker’s research focused on signaling pathways for the insulin and IGF–1 receptors, deciphering the structure and function of the insulin degrading enzyme and its role in insulin processing.
• William E. Gannon, Jr., MD, MBA – Dr. Gannon serves as Genprex’s Vice President of Regulatory Affairs. He is responsible for managing the Company’s regulatory affairs for its upcoming clinical trials. He also will serve as the Medical Monitor, interfacing with medical personnel at trial sites and assisting with FDA communication throughout the clinical trials. Dr. Gannon has more than 30 years of experience in the biotech and pharmaceutical industries, with expertise in clinical development, regulatory affairs and commercialization of products, and a strong background in oncology and gene therapy.

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, REQORSA™ ( quaratusugene ozeplasmid ), is being evaluated as a treatment for non-small cell lung cancer (NSCLC). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for REQORSA for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso®) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone .

For more information, please visit the Company’s web site at www.genprex.com or follow Genprex on Twitter , Facebook and LinkedIn .

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the effect of Genprex’s product candidates, alone and in combination with other therapies, on cancer and diabetes, regarding potential, current, regarding the Company’s future growth and financial status and regarding our commercial partnerships and intellectual property licenses. Risks that contribute to the uncertain nature of the forward-looking statements include the presence and level of the effect of our product candidates, alone and in combination with other therapies, on cancer; the timing and success of our clinical trials and planned clinical trials of REQORSA™ immunogene therapy drug, alone and in combination with targeted therapies and/or immunotherapies, and whether our other potential product candidates, including GPX-002, our gene therapy in diabetes, advance into clinical trials; the success of our strategic partnerships, including those relating to manufacturing of our product candidates; the timing and success at all of obtaining any FDA approvals of REQORSA and our other potential product candidates including whether we receive necessary approvals to commence clinical trials or benefit from fast track or similar regulatory designations; costs associated with developing our product candidates, whether we identify and succeed in acquiring other technologies and whether patents will ever be issued under patent applications that are the subject of our license agreements or otherwise. These and other risks and uncertainties are described more fully under the caption “Risk Factors” and elsewhere in our filings and reports with the United States Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210208005812/en/

Genprex, Inc.
(877) 774-GNPX (4679)

Investor Relations
GNPX Investor Relations
(877) 774-GNPX (4679) ext. #2
investors@genprex.com

Media Contact
Genprex Media Relations
Kalyn Dabbs
(877) 774-GNPX (4679) ext. #3
media@genprex.com

$FRSX Eye-Net to Conduct Technological Demonstrations in Collaboration with Leading European Cellular Provider

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., will conduct technological demonstrations over the 5G cellular network in collaboration with the innovation labs of a top multinational European cellular provider to test its Eye-Net(TM) Protect cellular-based vehicle-to-everything (“V2X”) accident prevention solution. According to the update, the cellular provider will conduct the technological demonstrations in front of different business units within its organization as well as several commercial partners. “Conducting technological demonstrations in collaboration with a leading European cellular provider marks a vote of confidence in Eye-Net’s innovative technology and potential. The technological demonstrations will run on the cellular provider’s 5G network, which is expected to enable enhanced performance, serving as a use case for a massive IoT application,” said Dror Elbaz, COO and deputy CEO of Eye-Net Mobile. “Eye-Net Protect provides real-time pre-collision alerts to all road users. A future partnership with a leading multinational cellular service provider may allow widespread deployment of Eye-Net Protect and may increase the chances of preventing accidents and saving lives.”

To view the full press release, visit https://ibn.fm/ZPxaA

About Foresight Autonomous Holdings Ltd.

Foresight is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration, sensor fusion and dense 3D point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$UUUU New Laser Scanners Could Hasten Decision-Making Processes on Mining Sites

$CNSP New Discovery May Revolutionize the Treatment of Diabetes

$MOTNF Announces Increase in PowerTap Investment, Details of Hydrogen Station Distribution Agreement

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, has increased its investment in PowerTap Hydrogen Fueling Corp., a company it had initially invested in on Oct. 27, 2020. Clean Power’s original investment in Power Tap was 90% equity interest; with its latest investment, that equity interest has increased to 94.5%. PowerTap is focused on expanding the nation’s cost-effective, hydrogen-fueling infrastructure in stages: engineering and design; ongoing development of PowerTap 3.0; and permitting and site preparation. PowerTap technology-based hydrogen fueling stations are already located in in California, Texas, Massachusetts and Maryland. In a second announcement, Clean Power announced that Power Tap had entered into a definitive agreement with the Andretti Group to install PowerTap’s innovative modular hydrogen production and dispensing units. The units will be installed in California this year, and the agreement outlines the deployment of more than 500 PowerTap modular hydrogen production and dispensing units in the United States by the end of 2025. “This exciting win-win relationship between PowerTap and the Andretti Group along with their industry partners will accelerate the deployment of our proprietary patented hydrogen production and dispensing technology, and provide a particularly compelling revenue share model with mutual benefit for all partners,” said PowerTap incoming president Salim Rahemtulla in the press release. “We are energized to be at the leading-edge of a renewable energy solution for the future during this period of accelerated energy transition.”

To view the full press releases, visit http://ibn.fm/UtFo7 and http://ibn.fm/s3Fl9

About Clean Power Capital Corp.

Clean Power is an investment company that specializes in investing into private and public companies opportunistically that may be engaged in a variety of industries, with a current focus in the health and renewable energy industries. In particular, the investment mandate is focused on high-return investment opportunities, the ability to achieve a reasonable rate of capital appreciation and to seek liquidity in its investments. For more information about the company, please visit www.CleanPower.Capital.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at http://ibn.fm/MOTNF

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

$AZRX Announces Participation in BIO CEO & Investor Digital Conference

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that its CEO James Sapirstein will present at the virtual BIO CEO & Investor Digital Conference. The conference is slated for Feb. 16–18, 2021. During the online event, all registered attendees will be able to access Sapirstein’s presentation on demand. The presentation will include an overview of AzurRx BioPharma, including its business and clinical-development programs; Sapirstein will also talk about goals and accomplishments the company is working toward in 2021. Following the presentation, Sapirstein and other members of the AzurRx management team will be available to participate in virtual one-on-one meetings with any interested registered investors as well as pharmaceutical companies attending the event.

To register for the event, visit http://ibn.fm/WQqj5

To view the full press release, visit http://ibn.fm/8vjK6

About AzurRx BioPharma Inc.

AzurRx BioPharma is a clinical-stage biopharmaceutical company specializing in the development of targeted, nonsystemic therapies for gastrointestinal (“GI”) diseases. The company has a pipeline of three gut-restricted GI assets. The first is MS1819, a recombinant lipase biologic for the treatment of exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis and chronic pancreatitis, with two ongoing phase 2 clinical trials. The other two are clinical-stage therapies using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor: FW-420, for the treatment of grade 1 immune checkpoint inhibitor associated colitis (“ICI-AC”) and diarrhea in oncology patients, and FW-1022, for the treatment of COVID-19 gastrointestinal infections. The company is headquartered in Delray Beach, Florida, with clinical operations in Hayward, California. For more information, visit the company’s website at www.AzurRx.com.

NOTE TO INVESTORS: The latest news and updates relating to AZRX are available in the company’s newsroom at http://ibn.fm/AZRX

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

$PLTXF Expands Bloombox Club into Germany, Featured in CNET Article

PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the expansion of its popular plant subscription platform Bloomboxclub Limited (“Bloombox Club”) to Germany. According to the update, Bloombox Club, which was acquired by the company in November 2020, is expanding its popular indoor plant subscription platform to launch under the new domain, www.BloomboxClub.de in Germany and will offer the same features that made Bloombox Club successful in the United Kingdom. These features include its plant subscription service, extensive indoor plant selection, plant care and self-care packages, and a wide variety of pots and accessories. “We are really excited to be rolling Bloombox Club out into Germany,” said Dr. Katie Cooper, Bloombox Club founder. “The German plant market is ripe for a player like Bloombox Club. More than that, for us as a business it makes sense as we will get the chance to attract new customers while using our current supply chain that is already set up to deliver into other European countries.”

In addition, PlantX was featured in a CNET article titled, “11 plant delivery services and garden subscriptions compared: Bloomscape, The Sill, My Garden Box and more.” The piece reads, “This online marketplace likes to think of itself as a vegan version of Amazon. PlantX caries a sprawling inventory of plant-based products, including a variety of indoor house plants and succulents. It’s all reasonably priced too, with most clocking in under $50 and some small plants for as little as $6. What’s nice about PlantX is you can tack other items, including ready-to-eat, plant-based meals, to your order.”

To view the full press release and article, visit http://ibn.fm/Lbadt and http://ibn.fm/tPHHe

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s website at www.Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at http://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$NETE AI Could Help Find EV Charging Infrastructure Gaps by Reading User Reviews

$RACMF Launches First Enterprise Ecommerce Pilot

Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced the launch of a pilot agreement with Maplin Electronics, the UK’s leading online electronics retailer, to implement Loop’s real-time artificial intelligence analytics platform. “This opportunity with Maplin represents our first enterprise eCommerce retailer, providing Loop with a tremendous opportunity to demonstrate the power of our real-time, artificial intelligence-driven engagement to online customers,” said Loop Insights CEO Rob Anson. “Loop will deliver operational efficiencies for Maplin by providing real-time intelligence focused on supply chain and demand analysis, as well as inventory and fulfillment analytics, enabling us to showcase our AI forecasting tools. I have every reason to believe the pilot will be a great success for Maplin and open up the door to further lucrative global enterprise eCommerce opportunities.”

To view the full press release, visit https://ibn.fm/piP1U

About Loop Insights Inc.

Loop Insights is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing and contactless solutions to the brick-and-mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. For more information, visit the company’s website at www.LoopInsights.ai.

NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at http://ibn.fm/RACMF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$ICLK Shares of iClick Interactive Rise to a New 52-Week High

iClick Interactive Asia Group Limited (NASDAQ:ICLK) traded today at a new 52-week high of $17.50. This new high was reached on below average trading volume as 366,000 shares traded hands, while the average 30-day volume is approximately 2.1 million shares.

Over the past year, iClick Interactive Asia Group Limited has traded in a range of $3.46 to $17.50 and is now at $16.48, 376% above that low.

iClick Interactive Asia Group Limited (NASDAQ:ICLK) is currently priced 6.2% above its average consensus analyst price target of $15.46.

iClick Interactive Asia Group Ltd is an independent online marketing and enterprise data solutions provider in China. It serves as an integrated cross-channel gateway that provides marketers with innovative and cost-effective ways to optimize their online marketing efforts throughout their marketing cycle and achieve their branding and performance-based marketing goals. It has two operating segments: Marketing Solutions, and Enterprise Solutions. Geographically, it derives majority revenue from PRC and also has a presence in Hong Kong and other countries.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

$CBDHF Hopes as TSX Launch Completed

$GNPX Joins Millions to Recognize World Cancer Day

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it joins with millions of healthcare advocates around the world in support of World Cancer Day. The designation seeks to raise awareness, elevate public understanding of the global cancer burden, promote greater equity and ensure that cancer control continues to be a priority in the world health and development agenda. “At Genprex, our primary focus is on the patients and communities we serve. Toward that end, we are relentless in our pursuit to bring innovative and life-saving oncology treatments to patients suffering with cancers for which there are limited or no treatment options,” said Rodney Varner, CEO of Genprex. “This World Cancer Day, we extend great appreciation to our research colleagues around the world who are working to alleviate the global cancer burden and to the patients who graciously offer their support through participation in clinical trials in the hope of finding new and effective treatments, not only for themselves, but for those who come after them.”

To view the full press release, visit: https://ibn.fm/a0OBL

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate, “REQORSA(TM)” (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for REQORSA for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, visit the company’s web site at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

$EXROF Received Order for Up to 2,000 Coil Drivers from LAND Electric Motorcycles

Exro Technologies (TSX.V: EXRO) (OTCQB: EXROF), a leading clean-technology company that has developed a new class of power electronics for electric motors and batteries, has announced an agreement with LAND (“LAND”) Electric Motorcycles to produce and deliver up to 2,000 Coil Drivers in the first year of the contract. The first unit will be shipped this month for testing, which should be completed by the end of Q2. LAND will integrate the Coil Drivers into its District motorcycle to optimize performance; the District model features an innovative vehicle design that delivers an enhanced experience for riders. The integration of the Coil Driver is intended to enhance the District’s performance as well as introduce a new powertrain system solution option for bikes in the electric motorcycle space. Based in Ohio, LAND is a fast-growing company operating in the nascent lightweight electric motorcycles market. “We are so glad to be collaborating with LAND to optimize their motorcycle’s powertrain,” said Exro CEO Sue Ozdemir in the press release. “This collaboration takes us another step closer to revenue growth and commercialization of our Coil Driver technology.”

To view the full press release, visit https://ibn.fm/897fo

About Exro Technologies Inc.

Exro is a clean-technology company pioneering intelligent control solutions in power electronics to help solve the most challenging problems in electrification. Exro has developed a new class of control technology that expands the capabilities of electric motors, generators and batteries. Exro enables the application to achieve more with less energy consumed. Exro’s advanced motor control technology, the Coil Driver, expands the capabilities of powertrains by enabling two separate torque profiles within a given motor. A major advancement in the sector, dynamic motor configuration enables efficiency optimization for each operating mode resulting in reduction of energy consumption. The controller automatically selects the appropriate configuration in real time so that power and efficiency are intelligently optimized. For more information about the company, please visit www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

$CNSP on the Verge of Changing History with Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, has set sights on an encouraging future for glioblastoma patients with its upcoming Phase 2 trial of Berubicin. The article detailing this groundbreaking news quoted the company’s CEO John Climaco as saying, “Anthracyclines as a class of chemotherapy have been used for over 60 years to treat a variety of cancers… However, historically, anthracyclines have never been used to treat primary or metastatic brain cancers because scientists could not demonstrate that anthracyclines were able to cross the blood-brain barrier and achieve significant levels of activity in the brain. Berubicin may change that history because it is the first anthracycline that, based on limited clinical data, appears to cross the blood-brain barrier and achieve drug levels critical for efficacy against central nervous system malignancies.” This is welcome news for glioblastoma patients, given that they “have a median survival rate of 14.6 months from the date of the malignancy’s diagnosis.” Berubicin was the focus of another company’s Phase 1 testing, conducted in 2006 with 25 participants. “11 of them (44%) achieved ‘statistically significant improvement in clinical benefit,’ and one of them continued to survive completely cancer-free as of last February 20.”

To view the full article, visit: https://ibn.fm/66LB9

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. For more information, visit the company’s website at www.CNSPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at http://ibn.fm/CNSP

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

$BRSF Offers Possible Solution for Detecting and Studying Parkinson’s

$BHAT Secures $7.59M in Registered Direct Offering

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced that it has closed a registered direct offering with two institutional investors for the purchase and sale of 7,160,000 of its ordinary shares. Blue Hat secured gross proceeds of $7,589,600, before deducting the placement agent’s fees and other estimated offering expenses, with each of the shares sold at a price of $1.06. The company also issued to the investors unregistered warrants to purchase up to 3,580,000 ordinary shares in a concurrent private placement. The warrants have an exercise price of $1.33 per share, will be exercisable immediately and will expire three years following the date of issuance. Blue Hat has 46,973,660 ordinary shares outstanding after the closing.

To view the full press release, visit http://ibn.fm/bBDa4

About Blue Hat

Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games and toys with mobile-game features. The company’s entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, please visit the company’s investor relations website at www.IR.BlueHatGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://ibn.fm/BHAT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$POAI Announces Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has received a letter from the Listing Qualifications Department of the Nasdaq Stock Market Inc. (NASDAQ). The letter informed Predictive Oncology that the company had regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the exchange’s listing rules. In October 2020, POAI had been notified by NASDAQ that it no longer met the organization’s minimum price bid requirement because it’s closing bid price per share had been below $1 for a period of 30 consecutive business days. The receipt of the most recent letter means that from Jan. 19, 2021, to Feb. 1, 2021, which covers the required last 10 consecutive business days, the closing bid price of Predictive Oncology’s common stock has been at $1 per share or greater, which means the company has regained compliance with the minimum bid price requirement. NASDAQ noted that it considers the matter now closed.

To view the full press release, visit http://ibn.fm/qVWOF

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Soluble Biotech.  Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA (“DNA/RNA”) and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$PLTXF Featured in Forbes Article

PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) was featured in a recent Forbes article titled, “Sustainably-Focused, Plant-Based Online Groceries Are Thriving. Here’s Why.” The piece covers plant-based groceries and the fact that sustainability focused products are growing at a rate of 5.6 times that of other products in the consumer goods sector. The article reads, “Another driving force for healthy online shopping is the growing impact of the plant-based community. PlantX was born from a combination of the need for education in plant-based living and eating, and co-founder Sean Dollinger’s 20 plus years background in e-commerce. The concept, a one-stop-shop with more than 10,000 plant-based products that ship all over Canada and the USA, was created by merging the two to make a plant-based lifestyle more accessible to all.”

In addition, the company today announced its appointment of José Abbo, former chairman of Panama’s $1.5 billion Sovereign Wealth Fund and a prominent leader, writer and visionary in the capital markets sector, as chairman of the PlantX Advisory Team. Comprised of respected executives in the business, marketing and finance industries, the PlantX Advisory Team will play a key role in guiding the company’s growth-oriented business strategy. “We are thrilled and honoured to have Mr. Abbo join PlantX,” said Sean Dollinger, PlantX founder. “His appointment as the chairman of our Advisory Team is a testament to PlantX’s commitment to attracting exceptional professionals who are dedicated to our mission to improve lives and grow as leaders in the plant-based industry.”

To view the full article and press release, visit https://ibn.fm/hNSON and https://ibn.fm/4b9Cc

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s website at www.Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at http://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$KAVL Enters Strategic Agreement with Potential to Triple Its Distribution Points

Kaival Brands (OTCQB: KAVL), a company focused on generating stockholder value by incubating innovative products into mature and dominant brands, is the exclusive global distributor of all products manufactured by Bidi Vapor LLC. This includes Bidi Vapor’s primary offering, the Bidi(R) Stick, as well as the Bidi(R) Pouch, a tobacco-free nicotine pouch. Today Kaival Brands announced its entry into an agreement with H.T. Hackney Co., a longstanding convenience store distribution leader, under which Hackney can now purchase the Bidi(R) Sticks for distribution.  This new partnership with Knoxville, Tennessee-based, 100-year-old Hackney, with over 20 distribution centers throughout the Southeast and Midwest supporting approximately 25,000 convenience stores, represents Kaival Brands’ largest single distribution agreement to date. “We are enthusiastic and humbled by Hackney’s embrace of the Bidi(R) Stick. This new agreement has the potential to triple our distribution points, which, if that occurs, could increase our previously forecasted revenue projections,” said Niraj Patel, CEO of Kaival Brands. “It is an honor to be affiliated with a company of Hackney’s stature and history, and further validates the innovative Bidi(R) Stick as a category leader. We look forward to a very fruitful relationship.”

To view the full press release, visit https://ibn.fm/f9Ntd

About Kaival Brands Innovations Group Inc.

Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. The company’s vision is to develop internally, acquire, own, or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. For more information, visit the company’s website at www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

$ICLK The Winning Streak Continues

iClick Interactive Asia Group Limited (NASDAQ:ICLK) traded today at a new 52-week high of $17.24. This new high was reached on below average trading volume as 366,000 shares traded hands, while the average 30-day volume is approximately 2.1 million shares.

iClick Interactive Asia Group Ltd is an independent online marketing and enterprise data solutions provider in China. It serves as an integrated cross-channel gateway that provides marketers with innovative and cost-effective ways to optimize their online marketing efforts throughout their marketing cycle and achieve their branding and performance-based marketing goals. It has two operating segments: Marketing Solutions, and Enterprise Solutions. Geographically, it derives majority revenue from PRC and also has a presence in Hong Kong and other countries.

iClick Interactive Asia Group Limited share prices have moved between a 52-week high of $17.24 and a 52-week low of $3.46 and are now trading 379% above that low price at $16.58 per share.

Based on a current price of $16.58, iClick Interactive Asia Group Limited is currently 6.8% above its average consensus analyst price target of $15.46.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer